News – Page 879 – Endpoints News

FDA finalizes guidance on adaptive trial designs

6 years ago

Astellas snags a gene therapy upstart with $3B buyout bid — inspiring forecasts of more M&A ahead

6 years ago

FDA to Lexicon: Yeah, that's still gonna be a no from us

6 years ago

Incyte nabs priority review for bile duct cancer drug; Temasek shows interest in another Woodford darling — report

6 years ago

Pfizer's retired NASH drug shown to reduce liver fat, inspiring new faith in the DGAT2 pathway

6 years ago

Agios taps Bristol-Myers vet Bruce Car to replace retiring CSO

6 years ago

Neurocrine is beefing up its pipeline, splurging $50M on rights to an epilepsy drug

6 years ago

The race to best treat a disease long confused with MS heats up with Roche's PhIII results

6 years ago

Analyst Brian Skorney goes grizzly on Biogen’s Alzheimer’s ‘hype,’ ‘fearmongering’ and ‘statistical ...

6 years ago

Just days ahead of his big strategic reveal, Sanofi CEO Paul Hudson lines up a $350M sale

6 years ago

Shaking up China's PD-(L)1 reimbursement landscape, Innovent, Eli Lilly earn coveted spot on national coverage

6 years ago

AstraZeneca gains a speedy Imfinzi review in race to beat Roche on frontline SCLC

6 years ago

Baker Bros. places a $250M bet on a potential rival to Regeneron and Novartis — with a $1B-plus payoff on the line

6 years ago

Numero quattro: Immunology experts at deal-focused IFM line up $55.5M for the next leg of their drug exploration ...

6 years ago

Novartis, Vertex outline big gene therapy plans — fueling a global boom

6 years ago

Mass General team presents mouse data to back the case for using reformulated asthma drug to treat ALS

6 years ago

Biotech vet Paul Brennan takes helm at regenerative med biotech; Axcella names CFO

6 years ago

Insider account of UCB’s $2.1B deal to buy Ra Pharma spotlights a disciplined M&A strategy — and $120M windfall ...

6 years ago

Korean biotech’s shares soar for a 'best of ESMO' award it never received

6 years ago

J&J, Teva and four others under criminal probe as feds investigate opioid makers for failing to monitor distribution

6 years ago

FDA approves 5 new costly drugs well ahead of PDUFA dates

6 years ago

Feds add fraud charges to the multitude of accusations made against former MiMedx execs

6 years ago

Merck adds another OK to Keytruda scoreboard; Ardelyx, Kyowa Kirin broadens partnership beyond tenapanor

6 years ago

Roche's Xofluza may give rise to resistant strains, raising fears of a 'worst case scenario'

6 years ago

First page Previous page 876 877 878879880 881 882 Next page Last page